Regencell Bioscience (RGC)

• Market cap: $12.7B
• 1 day: 1.06%
• 5 days: -4.93%
• 1 month: -2.13%
• 3 months: 9.33%
• 6 months: 56.62%
• Year to date: 24.98%
• 1 year: 2,697.52%
• 5 years: 9,190.63%
• 10 years: 9,190.63%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 10